Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 3Gastrointestinal 3NET 1Endocrine 1Classical hematology 1

Conditions

Neoplasms 5Splenomegaly 2Leukemia 2Fatigue 2Anemia, Sickle Cell 2Anemia 2Weight Loss 1Venous Thromboembolism 1Thrombocytopenia 1Smoking Cessation 1Smoking 1Primary Myelofibrosis 1Plexosarcoma 1Ovarian Neoplasms 1Myelodysplastic Syndromes 1Multiple Myeloma 1Lymphoma, Non-Hodgkin 1Lymphocytosis 1Lymphadenopathy 1Leukemia, Lymphocytic, Chronic, B-Cell 1Hodgkin Disease 1Gastrointestinal Stromal Tumors 1Fever 1Febrile Neutropenia 1Fanconi Anemia, Complementation Group D1 1Cancer-related Venous Thromboembolism 1Breast Neoplasms 1Anemia, Iron-Deficiency 1Anemia, Aplastic 1

Interventions

ferric carboxymaltose 1Surveys and Questionnaires 1Iron-Dextran Complex 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Gastrointestinal Stromal Tumors × Surveys and Questionnaires × Classical hematology × Clear all
NCT02949947 2020-04-06

Efficacy of Ferric Carboxymaltose in Gastrointestinal Stromal Tumor (GIST) Patients With Iron Deficiency Anemia (IDA) Receiving Systemic Therapy

M.D. Anderson Cancer Center

Phase 2 Terminated
3 enrolled 5 charts
Classical hematologyGastrointestinalSarcoma

Plexosarcoma, Anemia, Iron-Deficiency, Gastrointestinal Stromal Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡